Evaluation of Patients With Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT00001971
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 2–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 8050
- US sites recruiting
- 1
- Study start
- May 27, 1992
- Record last updated
- October 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver.
Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After the initial visit subjects will be requested to follow-up once a year at the outpatient department for a similar check-up.
Additional tests may be requested throughout the study to provide information for other research studies and individual consent will be requested. These tests may include liver biopsies, skin biopsies, and / or specialized blood, plasma, and lymphocyte examinations.
Subjects that qualify for medications presently being studied may be offered the opportunity to benefit from experimental therapy.
Conditions: Hepatitis D; Hepatitis C; Hepatitis B; Liver Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- INCLUSION CRITERIA:
Affected Subjects
In order to be eligible to participate in this study, an affected participant must meet all of the following criteria:
- >=2 years of age.
- Meets one of the following:
- Suspected or evidence of acute or chronic liver disease on evaluation by a referring licensed independent practitioner (LIP), OR
- At risk for acute or chronic liver disease
Healthy Volunteers
In order to be eligible to participate in this study, a healthy volunteer must meet all of the following criteria:
- >= 18 years of age.
- In good general health as evidenced by medical history
EXCLUSION CRITERIA
Affected Participants
An affected participant who meets any of the following criteria will be excluded from participation in this study:
- History of significant medical illnesses that might interfere with prolonged follow up evaluation
Healthy Volunteers
A healthy volunteer who meets any of the following criteria will be excluded from participation in this study:
- Any chronic medical condition, including (but not limited to) heart, kidney, or lung diseases
- Taking any regular medications or supplements (with the exception of regular multivitamins and/or oral contraceptives)
- Average alcohol consumption > 1 drink/day in past 6 months, per self-report
- History of liver disease (with the exception of neonatal jaundice)
- History of severe illness, infection or major surgery in the past year
- History of cancer (with the exception of basal cell carcinoma resected > 1 year prior to enrollment)
- BMI \< 18 or BMI >25
- Hemoglobin \< 11 (women) or hemoglobin \< 12 (men)
- ALT >35 (men) or ALT >25 (women)
- Alkaline Phosphatase >= 150
- Bilirubin >2 g/dL
- HIV positive, Anti-HCV positive, HBsAg positive or Anti-HBc positive
- Pregnancy
- Inability to provide informed consent
Recruiting US locations
National Institutes of Health Clinical Center
Bethesda, MD 20892
Study contacts (from the official record)
- Patricia E Alcivar · (301) 435-6121 · patricia.alcivar@nih.gov
- T. Jake Liang, M.D. · (301) 496-1721 · jakel@mail.nih.gov
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55